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ABSTRACT
The short gut syndrome can lead to multiple metabolic disorders along with chronic
malnutrition. Such patients can develop changes in mental status due to metabolic
alterations. We present a case of an eleven-year-old male who presented to the hospital with an altered mental state. There were repeated admissions to the hospital with
similar complaints with non-conclusive cerebrospinal fluid analysis and normal neuroimaging findings. The patient suffered from chronic malnutrition and multiple hospitalizations with altered mental status, encephalopathy. However, he responded well to
bicarbonate therapy and prophylactic metronidazole treatment.
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INTRODUCTION
The post-natal or premature loss of small bowel more
than fifty percent with or without large intestinal
loss is known as short bowel syndrome (SBS). This
condition can lead to lactic acidosis and chronic
malnutrition.1 Congenital SBS usually presents as
malrotation or gastroschisis in utero. Crohn’s disease,
trauma or other multiple small bowel conditions lead
to surgical resection of the bowel leading to SBS.2
CASE PRESENTATION
We present a case of an eleven-year-old male with
a past medical history of hypocomplementemia,
generalized clonic seizure (GTC), and gastroschisis,
who came to the hospital with complaints of
dizziness, confusion, and wobbly gait for twenty-four
hours prior to the visit. The patient mentioned about
passing out episodes of unspecified duration without
any random jerking body movements. When seen by
a neurology resident, the patient was alert, awake,
oriented, and following commands without any
problems. He was feeling sluggish and tired but was
cooperative during the physical exam (Table 1). The
laboratory findings have been mentioned in Table 2.
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The mother told the medical team about an episode
of confusion and episodes of slurred speech at home.
He denies any focal sensory or motor weakness
except broad-based gait, which started on the day of
the presentation. The patient also denies any urinary
or bowel incontinence, vision changes, speech,
or swallowing difficulties. Historically, the patient
had seen a pediatric neurologist in 2018 when he
was weaned off of levetiracetam after a normal
electroencephalogram (EEG). Magnetic resonance
imaging (MRI) of the brain showed no acute
abnormality. The cerebrospinal fluid analysis was
also non-contributory. In the past, the patient was
diagnosed with a congenital condition of short gut
syndrome with barium enema shown in Figure 1.
The patient was using a percutaneous endoscopic
gastrostomy (PEG) tube for feeding and had
persistent ileus with chronic constipation. The
patient had low bicarbonate levels and low pH
of 7.3 in serum. Pediatric gastroenterology team
recommended continuing the metronidazole with
dextrose 5% in water (D5W) 1,000 milliliter (mL) +
sodium bicarbonate 8.4% 150 milliequivalent (mEq) +
potassium chloride 20 mEQ. The patient took a high
calorie, high protein, low carbohydrate diet along
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TABLE 1: Physical Examination and Neurological Examination

TABLE 2: Pertinent Findings and Laboratory Workup.
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FIGURE 1 [A-E] Microcolon with gas-filled dilated loops of probable small bowel versus proximal
colon and completed bowel obstruction.
with vitamin B12, and zinc therapy. The laboratory
workup showed a persistent rising trend of D-lactate
levels over the years (Figure 2).
Over the years, the patient has been admitted
multiple times in the hospital with this condition,
with the rising trend observed in D-lactate levels.
His sodium levels were high on admission due to
dehydration and were normalized after intravenous
hydration. The patient had normal pyruvic acid levels.
Mentation and anion gap improved after hydration
and the patient was discharged with metronidazole
for the next three weeks. The patient’s gait instability
and ataxia improved after one week upon discharge.
DISCUSSION
Short bowel syndrome (SBS) has an incidence of
two persons per million per year. It causes lactic
acidosis due to resection of the intestine, such as
Roux-en-Y gastric bypass surgery.1 SBS is defined
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as surgical resection, congenital disability, or a
diseased portion of the small intestine, which results
in the inability to maintain nutrient balances on a
healthy diet.2 The small intestine is responsible for
most of the digestion and absorption of ingested
food.3 Naturally, if it were to get damaged, the
consequences would be dire. One such effect is the
accumulation of lactic acid. There are two different
optical isomers of lactic acid; D-lactate, which results
due to microbial flora in the intestine, and L-lactate
produced from glycolysis.3 The accumulation of
lactic acid can result from overproduction or underexcretion of the substrate. There is a wide array of
symptoms that patients experience; these include
altered mental status, neurological symptoms,
ataxia, and slurred speech. These symptoms
usually start after a high carbohydrate diet due to
malabsorption in a patient with SBS.4
The diagnostic criteria for lactic acidosis are a pH
level of less than 7.35 and a lactate level higher than
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FIGURE 2: Rising Trend of D-lactic Acidosis with Short Bowel Syndrome

5-6 mM/L.5 The accumulation of lactate results due
to the undigested carbohydrates that reach the
colon and are fermented. It can lower the intestinal
pH, alter the healthy flora of the region, and cause an
overgrowth of species, such as from the lactobacillus
family. These bacteria are the cause of D-lactic
acidosis. To date, there is no definitive treatment
for lactic acidosis, although recommendations
include avoiding antibiotics, taking bicarbonate
while maintaining hydration, and following a low
carbohydrate diet.
Another way to manage the refractory D-lactic
acidosis is by administering insulin, vancomycin,
neomycin, or hemodialysis.6 The report we
mentioned is unique because of the refractory and
resistant nature of lactobacillus over the year, and
the rising trend of D-lactate levels in the body which
may lead to end-organ damage and permanent
neurological injury. The patient in our reports also
falls under the metabolic encephalopathy with
anion gap metabolic acidosis with non-contributory
serum ammonia, liver, and renal profile. The
metabolic encephalopathy occurred as a result of
the accumulation of D-lactic acidosis and nutritional
deficiency over the years with gastrointestinal
problems. The limitation of our study was not
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collecting the gut microbiota for cultures since the
patient was treated clinically based on diagnosis with
SBS. There was no concern of seizure or post-ictal
confusion during the current presentation with the
past medical problem with GTC with antiepileptics
weaned off almost two years ago.
The definite management for chronic recurrent
D-lactic acidosis leading to encephalopathy is still
an area of debate and matter of future research. We
conclude that in patients with short gut syndrome
and chronic recurrent D-lactic acidosis, supportive
care should improve the neurological symptoms and
prevent irreparable damage.
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